Skip to Main Content

Paper Details

The promise of DNA damage response inhibitors for the treatment of glioblastoma.
Neurooncol Adv
23
2021
DNA, DNA-dependent protein kinase, GBM, GBM cells, Glioblastoma, PARP, ataxia telangiectasia, ataxia telangiectasia and Rad3-related, ataxia telangiectasia-mutated, glioblastoma, poly(ADP-ribose), primary brain tumor, tumor
Author NameAffiliation
Dimpy KoulThe University of Texas MD Anderson Cancer Center
Wai-Kwan Alfred YungThe University of Texas MD Anderson Cancer Center
Wai-Kwan Alfred YungThe University of Texas MD Anderson Cancer Center
John F de GrootThe University of Texas MD Anderson Cancer Center
  • 1 - 4

Datasets

Release 1.2